Pharmafile Logo
Pharmafocus logo
Advanced Search

inflammatory diseases

Showing 5 posts of 5 posts found.

GRI Bio announces two global patents granted for Europe and Japan

April 2, 2025
Research and Development Chronic Diseases, GRI Bio, autoimmune diseases, biotech, fibrotic diseases, inflammatory diseases, patent

GRI Bio, a biotech company that specialises in treatment for inflammatory, fibrotic and autoimmune diseases, has announced that two global …

News
clinical_trials

Kymera Therapeutics reports positive data in cancer drug trials

June 14, 2023
Research and Development Cancer, Kymera Therapeutics, Oncology, autoimmune diseases, clinical trials, inflammatory diseases

US clinical-stage biopharmaceutical company Kymera Therapeutics has shared new data regarding its oncology programmes KT-333 and KT-413, highlighting their robust dose-dependent …

News
fda_logo-web

US FDA committee recommends approval for Amgen’s biosimilar of AbbVie’s Humira

July 13, 2016
Research and Development, Sales and Marketing AbbVie, Amgen, Humira, US FDA, biosimilar, drug approval, drug trial, inflammatory diseases, rheumatoid arthritis

One of the world’s bestselling drug may soon have competition in the US markets after the regulators backed a biosimilar …

News
Gilead sign

Gilead steps in to rescue Galapagos RA drug

December 18, 2015
Sales and Marketing AbbVie, Gilead, Gilead Sciences, filgotinib, inflammation, inflammatory diseases, rheumatoid arthritis

Gilead Sciences is to pay $725million for the rights to filgotinib, a JAK1-selective inhibitor for rheumatoid arthritis and other inflammatory …

News

MRC, GSK and universities team up on inflammatory diseases

July 15, 2015
Research and Development COPD, GSK, MRC, Medical Research Council, fibrosis, inflammatory diseases

UK pharma giant GSK is partnering with the Medical Research Council, to study the biological mechanisms behind common inflammatory diseases. …

News
The Gateway to Local Adoption Series

Latest content

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026